-5%
Vonliv is prescribed for the treatment and prevention of various acid-related gastrointestinal conditions, including:
- Gastric ulcers
- Duodenal ulcers
- Reflux esophagitis
- Prevention of ulcer recurrence in patients taking low-dose aspirin or NSAIDs
- Helicobacter pylori eradication therapy (in combination with antibiotics) for:
- Gastric and duodenal ulcers
- Gastric MALT lymphoma
- Idiopathic thrombocytopenic purpura
- H. pylori gastritis or post-endoscopic resection of early gastric cancer
Use only as directed by a registered physician
Vonliv
Generic Name: Vonoprazan
Therapeutic Class: Potassium-Competitive Acid Blocker (P-CAB)
Dosage Forms: Tablet
Vonoprazan is a Potassium-Competitive Acid Blocker (P-CAB) that reversibly inhibits the H+, K+-ATPase enzyme in gastric parietal cells. Unlike PPIs, Vonliv does not require acid activation, allowing for rapid onset and sustained acid suppression. It binds directly and competitively with the proton pump, reducing gastric acid secretion and promoting mucosal healing.
